The lipid peroxidation product 4-hydroxynonenal impairs glutamate and glucose transport and choline acetyltransferase activity in NSC-19 motor neuron cells

Experimental Neurology

Volumn 155, Issue 1, 1999, Pages 1-10

  Pedersen, Ward A ^a   Cashman, Neil R ^b   Mattson, Mark P ^a  

^a UNIVERSITY OF KENTUCKY   (United States)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Amyotrophic lateral sclerosis; Excitotoxicity free radicals; Glutathione; Iron; Oxidative stress; Vitamin E

Indexed keywords

4 HYDROXYNONENAL; ALPHA TOCOPHEROL; CHOLINE ACETYLTRANSFERASE; GALLIC ACID PROPYL ESTER; GLUCOSE; GLUTAMIC ACID; MEMBRANE LIPID; NEUROFILAMENT PROTEIN;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL DEATH; DEGENERATIVE DISEASE; ENZYME ACTIVITY; GLUCOSE TRANSPORT; LIPID PEROXIDATION; MOUSE; NERVE CELL DEGENERATION; NONHUMAN; OXIDATIVE STRESS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN MODIFICATION;

EID: 0033004618     PISSN: 00144886     EISSN: None     Source Type: Journal    
DOI: 10.1006/exnr.1998.6890     Document Type: Article

References (75)

1. Alexianu M. E., Ho B. K., Mohamed A. H., La Bella V., Smith R. G., Appel S. H. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann. Neurol. 36:1994;846-858.
2. Azzouz M., Leclerc N., Gurney M., Warter J. M., Poindron P., Borg J. Progressive motor neuron impairment in an animal model of familial amyotrophic lateral sclerosis. Muscle Nerve. 20:1997;45-51.
3. Beckman J. S., Crow J. P. Pathological implications of nitric oxide, superoxide and peroxynitrite formation. Biochem. Soc. Trans. 21:1993;330-334.
4. Bensimon G., Lacomblez L., Meininger V. The ALS/Riluzole Study Group. A controlled trial of riluzole in amyotrophic lateral sclerosis. N. Engl. J. Med. 330:1994;585-591.
5. Blanc E. M., Keller J. N., Fernandez S., Mattson M. P. 4-hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia. 22:1998;149-160.
6. Blanc E. M., Kelly J. F., Mark R. J., Mattson M. P. 4-hydroxynonenal, an aldehydic product of lipid peroxidation, impairs signal transduction associated with muscarinic acetylcholine and metabotropic glutamate receptors: Possible action on Gαq/11. J. Neurochem. 69:1997;570-580.
7. Bonfoco E., Krainc D., Ankarcrona M., Nicotera P., Lipton S. A. Apoptosis and necrosis: Two distinct events induced, respectively, by mild and intense insults with Nd. Proc. Natl. Acad. Sci. USA. 92:1995;7162-7166.
8. Cashman N. R., Durham H. D., Blusztajn J. K., Oda K., Tabira T., Shaw I. T., Dahrouge S., Antel J. P. Neuroblastoma x spinal cord (NSC) hybrid cell lines resemble developing motor neurons. Dev. Dynamics. 194:1992;209-221.
9. Chiueh C. C., Wu R. M., Mohanakumar K. P., Sternberger L. M., Krishna G., Obata T., Murphy D. L. In vivo. Ann. N.Y. Acad. Sci. 738:1994;25-36.
10. Couratier P., Sindou P., Esclaire F., Louvel E., Hugon J. Neuroprotective effects of riluzole in ALS CSF toxicity. NeuroReport. 5:1994;1012-1014.
11. Cudkowicz M. E., McKenna-Yasek D., Sapp P. E., Chin W., Geller B., Hayden D. L., Schoenfeld D. A., Hosler B. A., Horvitz H. R., Brown R. H. Epidemiology of mutations in superoxide dismutase in amyotrophic lateral sclerosis. Ann. Neurol. 41:1997;210-221.
12. Dal Canto M. C., Gurney M. E. Neuropathological changes in two lines of mice carrying a transgene for mutant human Cu,Zn SOD, and in mice overexpressing wild type human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res. 676:1995;25-40.
13. Deng H. X. Amyotrophic lateral sclerosis and structural defects in Cu,Zn superoxide dismutase. Science. 261:1993;1047-1051.
14. Dexter D. T., Holley A. E., Flitter W. D., Slater T. F., Wells F. R., Daniel S. E., Lees A. J., Jenner P., Marsden C. D. Increased levels of lipid hydroperoxides in the parkinsonian substantia nigra: An HPLC and ESR study. Mov. Disord. 9:1994;92-97.
15. Engelhardt J. I., Siklos L., Appel S. H. Altered calcium homeostasis and ultrastructure in motoneurons of mice caused by passively transferred anti-motoneuronal IgG. J. Neuropathol. Exp. Neurol. 56:1997;21-39.
16. Esterbauer H., Schaur R. J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Rad. Biol. Med. 11:1991;81-128.
17. Furukawa K., Estus S., Fu W., Mattson M. P. Neuroprotective action of cycloheximide involves induction of Bcl-2 and antioxidant pathways. J. Cell Biol. 136:1997;1137-1150.
18. Goodman Y., Bruce A. J., Cheng B., Mattson M. P. Estrogens attenuate and corticosterone exacerbates excitotoxicity, oxidative injury, and amyloid β-peptide toxicity in hippocampal neurons. J. Neurochem. 66:1996;1836-1844.
19. Grynkiewicz G., Poenie M., Tsien R. Y. A new generation of calcium indicators with greatly improved fluorescence properties. J. Biol. Chem. 260:1985;3440-3450.
20. Gurney M. E., Cutting F. B., Zhai P., Doble A., Taylor C. P., Andrus P. K., Hall E. D. Benefit of vitamin E, riluzole, and gabapentin in a transgenic model of familial amyotrophic lateral sclerosis. Ann. Neurol. 39:1996;147-157.
21. Gurney M. E., Pu H., Chiu A. Y., Dal Canto M. C., Polchow C. Y., Alexander D. D., Caliendo J., Hentati A., Kwon Y. W., Deng H. X. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 264:1994;1772-1775.
22. Hall E. D. Lipid peroxidation. Adv. Neurol. 71:1996;247-257.
23. Hasham M. I., Naumann D., Kim S. U., Cashman N. R., Quamme G. A., Krieger C. Intracellular calcium concentrations during metabolic inhibition in the motoneuron cell line NSC-19. Can. J. Physiol. Pharmacol. 72:1994;728-737.
24. Ho B. K., Alexianu M. E., Colom L. V., Mohamed A. H., Serrano F., Appel S. H. Expression of calbindin-D28K in motoneuron hybrid cells after retroviral infection with calbindin-D28K cDNA prevents amyotrophic lateral sclerosis IgG-mediated cytotoxicity. Proc. Natl. Acad. Sci. USA. 93:1996;6796-6801.
25. Ince P. G., Shaw P. J., Candy J. M., Mantle D., Tandon L., Ehmann W. D., Markesbery W. R. Iron, selenium and glutathione peroxidase activity are elevated in sporadic motor neuron disease. Neurosci. Lett. 182:1994;87-90.
26. Jackson M., Morrison K. E., Al-Chalabi A., Bakker M., Leigh P. N. Analysis of chromosome 5q13 genes in amyotrophic lateral sclerosis: Homozygous NAIP deletion in a sporadic case. Ann. Neurol. 39:1996;796-800.
27. Keller J. N., Mark R. J., Bruce A. J., Blanc E. M., Rothstein J. D., Uchida K., Mattson M. P. 4-hydroxynonenal, an aldehydic product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997;685-696.
28. Keller J. N., Pang Z., Geddes J. W., Begley J. G., Germeyer A., Waeg G., Mattson M. P. Impairment of glucose and glutamate transport and induction of mitochondrial oxidative stress and dysfunction in synaptosomes by amyloid-β peptide: Role of the lipid peroxidation product 4-hydroxynonenal. J. Neurochem. 69:1997;273-284.
29. Kostic V., Jackson-Lewis V., de Bilbao F., Dubois-Dauphin M., Przedborski S. Bcl-2: Prolonging life in a transgenic mouse model of familial amyotrophic lateral sclerosis. Science. 277:1997;559-562.
30. Kruman I., Bruce A. J., Bredesen D. E., Waeg G., Mattson M. P. Evidence that 4-hydroxynonenal mediates oxidative stress-induced neuronal apoptosis. J. Neurosci. 17:1997;5089-5100.
31. Li X., Song L., Jope R. S. Cholinergic stimulation of AP-1 and NFkB transcription factors is differentially sensitive to oxidative stress in SH-SY5Y neuroblastoma: Relationship to phosphoinositide hydrolysis. J. Neurosci. 16:1996;5914-5922.
32. Lovell M. A., Ehmann W. D., Mattson M. P., Markesbery W. R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18:1997;457-461.
33. 2+. J. Neurosci. 15:1995;6239-6249.
34. Mark R. J., Lovell M. A., Markesbery W. R., Uchida K., Mattson M. P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68:1997;255-264.
35. Mark R. J., Pang Z., Geddes J. W., Uchida K., Mattson M. P. Amyloid β-peptide impairs glucose uptake in hippocampal and cortical neurons: Involvement of membrane lipid peroxidation. J. Neurosci. 17:1997;1046-1054.
36. Markesbery W. R., Ehmann W. D., Candy J. M., Ince P. G., Shaw P. J., Tandon L., Deibel M. A. Neutron activation analysis of trace elements in motor neuron disease spinal cord. Neurodegeneration. 4:1995;383-390.
37. Mattson M. P., Barger S. W., Begley J. G., Mark R. J. Calcium, free radicals, and excitotoxic neuronal death in primary cell culture. Methods Cell Biol. 46:1995;187-216.
38. Mattson M. P., Cheng B., Davis D., Bryant K., Lieberburg I., Rydel R. E. β-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. J. Neurosci. 12:1992;379-389.
39. Mattson M. P., Fu W., Waeg G., Uchida K. 4-hydroxynonenal, a product of lipid peroxidation, inhibits dephosphorylation of the microtubule-associated protein tau. NeuroReport. 8:1997;2275-2281.
40. Mattson M. P., Furukawa K., Bruce A. J., Mark R. J., Blanc E. Calcium homeostasis and free radical metabolism as convergence points in the pathophysiology of dementia. Molecular Mechanisms of Dementia. 1996;Humana Press. p. 103-143.
41. Medina L., Figueredo-Cardenas G., Rothstein J. D., Reiner A. Differential abundance of glutamate transporter subtypes in amyotrophic lateral sclerosis (ALS)-vulnerable versus ALS-resistant brain stem motor cell groups. Exp. Neurol. 142:1996;287-295.
42. Mitsumoto H. Diagnosis and progression of ALS. Neurology. 48:1997;2-8.
43. Montine T. J., Huang D. Y., Valentine W. M., Amarnath V., Saunders A., Weisgraber K. H., Graham D. G., Strittmatter W. J. Crosslinking of apolipoprotein E by products of lipid peroxidation. J. Neuropathol. Exp. Neurol. 55:1996;202-210.
44. Montine K. S., Olson S. J., Amarnath V., Whetsell W. O., Graham D. G., Montine T. Immunohistochemical detection of 4-hydroxy-2-nonenal adducts in Alzheimer's disease is associated with inheritance of APOE4. Am. J. Pathol. 150:1997;437-443.
45. Morrison B. M., Gordon J. W., Ripps M. E., Morrison J. H. Quantitative immunocytochemical analysis of the spinal cord in G86R superoxide dismutase transgenic mice: Neurochemical correlates of selective vulnerability. J. Comp. Neurol. 373:1996;619-631.
46. 2+. Ann. Neurol. 37:1995;102-109.
47. Mu X., He J., Anderson D. W., Trojanowski J. Q., Springer J. E. Altered expression of bcl-2 and bax mRNA in amyotrophic lateral sclerosis spinal cord motor neurons. Ann. Neurol. 40:1996;379-386.
48. Novelli A., Reilly J. A., Lyska P. C., Henneberry R. C. Glutamate becomes neurotoxic via the Nd. Brain Res. 451:1988;205-212.
49. Oda Y., Imai S., Nakanishi I., Ichikawa T., Deguchi T. Immunohistochemical study on choline acetyltransferase in the spinal cord of patients with amyotrophic lateral sclerosis. Pathol. Int. 45:1995;933-939.
50. Pedersen W. A., Fu W., Keller J. N., Markesbery W. R., Appel S. H., Smith R. G., Kasarskis E., Mattson M. P. Protein modification by the lipid peroxidation product 4-hydroxynonenal in the spinal cords of ALS patients. Ann Neurol. 1998.
51. Pedersen W. A., Guo Q., Hartman B. K., Mattson M. P. Nerve growth factor-independent reduction in choline acetyltransferase activity in PC12 cells expressing mutant presenilin-1. J. Biol. Chem. 272:1997;22397-22400.
52. Plaitakis A., Constantakakis E., Smithe J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in spinal cord and brain in amyotrophic lateral sclerosis. Ann. Neurol. 24:1988;446-449.
53. Rosen D. R. Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature. 362:1993;59-62.
54. Rothstein J. D., Bristol L. A., Hosler B., Brown R. H., Kuncl R. W. Chronic inhibition of superoxide dismutase produced apoptotic death of spinal neurons. Proc. Nat. Acad. Sci. USA. 91:1994;4155-4159.
55. Rothstein J. D., Martin L. J., Kuncl R. W. Decreased glutamate transport by the brain and spinal cord in amyotrophic lateral sclerosis. New Engl. J. Med. 326:1992;1464-1468.
56. Rothstein J. D., Tsai G., Kuncl R. W. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann. Neurol. 28:1990;18-25.
57. Rothstein J. D., VanKammen B. A., Levey A. I., Martin L. J., Kuncl R. W. Selective loss of glial glutamate transporter GLT-1 in amyotrophic lateral sclerosis. Ann. Neurol. 38:1995;73-84.
58. Sayre L. M., Zelasko D. A., Harris P. L. R., Perry G., Salomon R. G., Smith M. A. 4-hydroxynonenal-derived advanced lipid peroxidation end products are increased in Alzheimer's disease. J. Neurochem. 68:1997;2092-2097.
59. Siddique T. Molecular genetics of familial amyotrophic lateral sclerosis. Adv. Neurol. 56:1991;227-231.
60. ++. Free Rad. Biol. Med. 20:1996;215-223.
61. Siklos L., Engelhardt J., Harati Y., Smith R. G., Joo F., Appel S. H. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotropic lateral sclerosis. Ann. Neurol. 39:1996;203-216.
62. Smith R. G., Alexianu M. E., Crawford G., Nyormoi O., Stefani E., Appel S. H. Cytotoxicity of immunoglobulins from amyotrophic lateral sclerosis patients on a hybrid motoneuron cell line. Proc. Natl. Acad. Sci. USA. 91:1994;3393-3397.
63. Smith R. G., Hamilton S., Hofmann F., Schneider T., Nastainczyk W., Birnbaumer L., Stefani E., Appel S. H. Serum antibodies tol. N. Engl. J. Med. 327:1992;1721-1728.
64. 22. Biochem. J. 267:1990;453-459.
65. Springer J. E., Azbill R. D., Mark R. J., Begley J. G., Waeg G., Mattson M. P. 4-hydroxynonenal, a lipid peroxidation product, rapidly accumulates following spinal cord injury and inhibits glutamate uptake. J. Neurochem. 68:1997;2469-2476.
66. Tandan R., Bradley W. G. Amyotrophic lateral sclerosis. Part 1. Clinical features, pathology and ethical issues in management. Ann. Neurol. 18:1985;271-280.
67. Terro F., Lesort M., Viader F., Ludolph A., Hugon J. Antioxidant drugs block in vitro the neurotoxicity of CSF from patients with amyotrophic lateral sclerosis. NeuroReport. 7:1996;1970-1972.
68. Troost D., Aten J., Morsink F., de Jong J. M. Apoptosis in amyotrophic lateral sclerosis is not restricted to motor neurons. Bcl-2 expression is increased in unaffected postcentral gyrus. Neuropathol. Appl. Neurobiol. 21:1995;498-504.
69. Tu P. H., Raju P., Robinson K. A., Gurney M. E., Trojanowski J. Q., Lee V. M. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl. Acad. Sci. USA. 93:1996;3155-3160.
70. Wiedau-Pazos M. Altered reactivity of superoxide dismutase in familial amyotrophic lateral sclerosis. Science. 271:1996;515-518.
71. Wong P. C., Pardo C. A., Borchelt D. R., Lee M. K., Copeland N. G., Jenkins N. A., Sisodia S. S., Cleveland D. W., Price D. L. An adverse property of a familial ALS-linked SOD1 mutation causes motor neuron disease characterized by vacuolar degeneration of mitochondria. Neuron. 14:1995;1105-1116.
72. Wu D., Hersh L. B. Choline acetyltransferase: The first fifty years. J. Neurochem. 62:1994;1653-1663.
73. Yim M. B., Kang J. H., Yim H. S., Kwak H. S., Chock P. B., Stadtman E. R. A gain-of-function of an amyotrophic lateral sclerosis-associated Cu,Zn-superoxide dismutase mutant: An enhancement of free radical formation due to a decrease in Km for hydrogen peroxide. Proc. Natl. Acad. Sci. USA. 93:1996;5709-5714.
74. Yoshiyama Y., Yamada T., Asanuma K., Asahi T. Apoptosis related antigen, Le(Y) and nick-end labeling are positive in spinal motor neurons in amyotrophic lateral sclerosis. Acta Neuropathol. 88:1994;207-211.
75. Zhang J.-R., Scherch H. M., Hall E. D. Direct measurement of lipid hydroperoxides in iron-dependent spinal neuronal injury. J. Neurochem. 66:1996;355-361.